In addition, NR3C2 has been reported as a tumor suppressor gene in clear cell renal cell carcinoma, pancreatic cancer, liver cancer, colon adenocarcinoma, oral squamous cell carcinoma, and glioblastoma cancer [10–15]. This evidence concerns the gene NR3C2 and familial pancreatic carcinoma.